Literature DB >> 19271226

Histopathologic predictors of pilocytic astrocytoma event-free survival.

Kathleen M Tibbetts1, Ryan J Emnett, Feng Gao, Arie Perry, David H Gutmann, Jeffrey Russell Leonard.   

Abstract

Pilocytic astrocytoma (PA) is the most common pediatric brain tumor. Most arise in the cerebellum, but they also can develop in the brainstem and optic nerve, where gross total resection (GTR) is not possible. In the absence of GTR, significant variability in both clinical behavior and histology exists. To identify potential markers associated with poor clinical outcome, we retrospectively assessed pathological features in 107 patients with PAs. We identified four pathological features (necrosis, oligodendroglioma-like features, vascular hyalinization, and calcification) that showed a significant correlation with decreased event-free survival (EFS). Similar to previous reports, we also found that PAs involving the optic pathway were associated with worse EFS compared with those arising in other locations. In contrast, mitotic index, p53 immunoreactivity and hyperactivation of several mitogenic signaling pathways (MAPK, CREB, mTOR) did not demonstrate a statistically significant relationship with EFS. Lastly, we did find a statistical trend between EFS and the number of CD68+ cells, suggesting that non-neoplastic elements of the tumor microenvironment may influence subsequent growth and clinical recurrence. Collectively, the identification of specific histopathologic features associated with clinical outcome may improve our ability to determine which PAs are more likely to exhibit clinical progression and require more vigilant observation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19271226     DOI: 10.1007/s00401-009-0506-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  23 in total

1.  Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas.

Authors:  Craig Horbinski; Ronald L Hamilton; Yuri Nikiforov; Ian F Pollack
Journal:  Acta Neuropathol       Date:  2010-01-01       Impact factor: 17.088

2.  Increased β-catenin/Tcf signaling in pilocytic astrocytomas: a comparative study to distinguish pilocytic astrocytomas from low-grade diffuse astrocytomas.

Authors:  Gangadhara Reddy Sareddy; Khamushavalli Geeviman; Manas Panigrahi; Sundaram Challa; Anita Mahadevan; Phanithi Prakash Babu
Journal:  Neurochem Res       Date:  2011-09-16       Impact factor: 3.996

3.  Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas--an assessment of 3 new variables in predicting clinical outcome.

Authors:  Linda R Margraf; Lynn Gargan; Yasmeen Butt; Nirupa Raghunathan; Daniel C Bowers
Journal:  Neuro Oncol       Date:  2011-06-08       Impact factor: 12.300

4.  PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma.

Authors:  Erika F Rodriguez; Bernd W Scheithauer; Caterina Giannini; Amanda Rynearson; Ling Cen; Bridget Hoesley; Heather Gilmer-Flynn; Jann N Sarkaria; Sarah Jenkins; Jin Long; Fausto J Rodriguez
Journal:  Acta Neuropathol       Date:  2010-11-28       Impact factor: 17.088

5.  Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.

Authors:  Grant W Simmons; Winnie W Pong; Ryan J Emnett; Crystal R White; Scott M Gianino; Fausto J Rodriguez; David H Gutmann
Journal:  J Neuropathol Exp Neurol       Date:  2011-01       Impact factor: 3.685

6.  A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma.

Authors:  Maura Massimino; Filippo Spreafico; Daria Riva; Veronica Biassoni; Geraldina Poggi; Carlo Solero; Lorenza Gandola; Lorenzo Genitori; Piergiorgio Modena; Fabio Simonetti; Paolo Potepan; Michela Casanova; Cristina Meazza; Carlo A Clerici; Serena Catania; Iacopo Sardi; Felice Giangaspero
Journal:  J Neurooncol       Date:  2010-02-12       Impact factor: 4.130

7.  Insulin-like growth factor 2 mRNA binding protein 3 expression is an independent prognostic factor in pediatric pilocytic and pilomyxoid astrocytoma.

Authors:  Valerie N Barton; Andrew M Donson; Diane K Birks; Bette K Kleinschmidt-DeMasters; Michael H Handler; Nicholas K Foreman; Sarah Z Rush
Journal:  J Neuropathol Exp Neurol       Date:  2013-05       Impact factor: 3.685

8.  Rapid recurrence and malignant transformation of pilocytic astrocytoma in adult patients.

Authors:  Jason A Ellis; Allen Waziri; Casilda Balmaceda; Peter Canoll; Jeffrey N Bruce; Michael B Sisti
Journal:  J Neurooncol       Date:  2009-06-17       Impact factor: 4.130

9.  Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas.

Authors:  Shuichi Okubo; Hai-Ning Zhen; Nobuyuki Kawai; Yoshihiro Nishiyama; Reiji Haba; Takashi Tamiya
Journal:  J Neurooncol       Date:  2010-01-21       Impact factor: 4.130

Review 10.  Pathological and molecular advances in pediatric low-grade astrocytoma.

Authors:  Fausto J Rodriguez; Kah Suan Lim; Daniel Bowers; Charles G Eberhart
Journal:  Annu Rev Pathol       Date:  2012-10-29       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.